DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways

Abstract

One aim for an HIV vaccine is to elicit neutralizing antibodies (Nab) that can limit replication of genetically diverse viruses and prevent establishment of a new infection. Thus, identifying the strengths and weaknesses of Nab during the early stages of natural infection could prove useful in achieving this goal. Here we demonstrate that viral escape readily occurred despite the development of high titer autologous Nab in two subjects with acute/early subtype C infection. To provide a detailed portrayal of the escape pathways, Nab resistant variants identified at multiple time points were used to create a series of envelope (Env) glycoprotein chimeras and mutants within the background of a corresponding newly transmitted Env. In one subject, Nab escape was driven predominantly by changes in the region of gp120 that extends from the beginning of the V3 domain to the end of the V5 domain (V3V5). However, Nab escape pathways in this subject oscillated and at times required cooperation between V1V2 and the gp41 ectodomain. In the second subject, escape was driven by changes in V1V2. This V1V2-dependent escape pathway was retained over time, and its utility was reflected in the virus’s ability to escape from two distinct monoclonal antibodies (Mabs) derivedmore » from this same patient via introduction of a single potential N-linked glycosylation site in V2. Spatial representation of the sequence changes in gp120 suggested that selective pressure acted upon the same regions of Env in these two subjects, even though the Env domains that drove escape were different. Together the findings argue that a single mutational pathway is not sufficient to confer escape in early subtype C HIV-1 infection, and support a model in which multiple strategies, including potential glycan shifts, direct alteration of an epitope sequence, and cooperative Env domain conformational masking, are used to evade neutralization.« less

Authors:
 [1];  [1];  [1];  [1];  [1];  [2];  [3];  [4];  [5];  [1];  [6];  [7];  [1]
  1. Emory University, Atlanta, GA (United States)
  2. Zambia Emory HIV Research Project, ZEHRP, Lusaka (Zambia); Zambia Blood Transfusion Service, Lusaka (Zambia)
  3. Zambia Emory HIV Research Project, ZEHRP, Lusaka (Zambia); Emory University, Atlanta, GA (United States)
  4. Public Health Research Institute., Newark, NJ (United States); University of Medicine and Dentistry, Newark, NJ (United States)
  5. University of Alabama, Birmingham, AL (United States)
  6. Tulane University, New Orleans, LA (United States)
  7. Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Publication Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institutes of Health (NIH); Bill and Melinda Gates Foundation
OSTI Identifier:
1627894
Grant/Contract Number:  
AC52-06NA25396; R01-AI58706; R01-AI51231; U01-AI78410; 37874; 38619
Resource Type:
Accepted Manuscript
Journal Name:
PLoS Pathogens
Additional Journal Information:
Journal Volume: 5; Journal Issue: 9; Journal ID: ISSN 1553-7374
Publisher:
Public Library of Science
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; HIV-1; glycosylation; hybridomas; protein sequencing; B cells; cloning; DNA cloning; polymerase chain reaction

Citation Formats

Rong, Rong, Li, Bing, Lynch, Rebecca M., Haaland, Richard E., Murphy, Megan K., Mulenga, Joseph, Allen, Susan A., Pinter, Abraham, Shaw, George M., Hunter, Eric, Robinson, James E., Gnanakaran, S., and Derdeyn, Cynthia A. Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways. United States: N. p., 2009. Web. doi:10.1371/journal.ppat.1000594.
Rong, Rong, Li, Bing, Lynch, Rebecca M., Haaland, Richard E., Murphy, Megan K., Mulenga, Joseph, Allen, Susan A., Pinter, Abraham, Shaw, George M., Hunter, Eric, Robinson, James E., Gnanakaran, S., & Derdeyn, Cynthia A. Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways. United States. https://doi.org/10.1371/journal.ppat.1000594
Rong, Rong, Li, Bing, Lynch, Rebecca M., Haaland, Richard E., Murphy, Megan K., Mulenga, Joseph, Allen, Susan A., Pinter, Abraham, Shaw, George M., Hunter, Eric, Robinson, James E., Gnanakaran, S., and Derdeyn, Cynthia A. Fri . "Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways". United States. https://doi.org/10.1371/journal.ppat.1000594. https://www.osti.gov/servlets/purl/1627894.
@article{osti_1627894,
title = {Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways},
author = {Rong, Rong and Li, Bing and Lynch, Rebecca M. and Haaland, Richard E. and Murphy, Megan K. and Mulenga, Joseph and Allen, Susan A. and Pinter, Abraham and Shaw, George M. and Hunter, Eric and Robinson, James E. and Gnanakaran, S. and Derdeyn, Cynthia A.},
abstractNote = {One aim for an HIV vaccine is to elicit neutralizing antibodies (Nab) that can limit replication of genetically diverse viruses and prevent establishment of a new infection. Thus, identifying the strengths and weaknesses of Nab during the early stages of natural infection could prove useful in achieving this goal. Here we demonstrate that viral escape readily occurred despite the development of high titer autologous Nab in two subjects with acute/early subtype C infection. To provide a detailed portrayal of the escape pathways, Nab resistant variants identified at multiple time points were used to create a series of envelope (Env) glycoprotein chimeras and mutants within the background of a corresponding newly transmitted Env. In one subject, Nab escape was driven predominantly by changes in the region of gp120 that extends from the beginning of the V3 domain to the end of the V5 domain (V3V5). However, Nab escape pathways in this subject oscillated and at times required cooperation between V1V2 and the gp41 ectodomain. In the second subject, escape was driven by changes in V1V2. This V1V2-dependent escape pathway was retained over time, and its utility was reflected in the virus’s ability to escape from two distinct monoclonal antibodies (Mabs) derived from this same patient via introduction of a single potential N-linked glycosylation site in V2. Spatial representation of the sequence changes in gp120 suggested that selective pressure acted upon the same regions of Env in these two subjects, even though the Env domains that drove escape were different. Together the findings argue that a single mutational pathway is not sufficient to confer escape in early subtype C HIV-1 infection, and support a model in which multiple strategies, including potential glycan shifts, direct alteration of an epitope sequence, and cooperative Env domain conformational masking, are used to evade neutralization.},
doi = {10.1371/journal.ppat.1000594},
journal = {PLoS Pathogens},
number = 9,
volume = 5,
place = {United States},
year = {Fri Sep 18 00:00:00 EDT 2009},
month = {Fri Sep 18 00:00:00 EDT 2009}
}

Works referenced in this record:

Autologous HIV-1 Neutralizing Antibodies: Emergence of Neutralization-Resistant Escape Virus and Subsequent Development of Escape Virus Neutralizing Antibodies
journal, January 1992

  • Arendrup, Maiken; Nielsen, Claus; Hansen, John-Erik Stig
  • JAIDS Journal of Acquired Immune Deficiency Syndromes, Vol. 5, Issue 3
  • DOI: 10.1097/00126334-199203000-00012

Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing
journal, February 2008

  • Salazar-Gonzalez, J. F.; Bailes, E.; Pham, K. T.
  • Journal of Virology, Vol. 82, Issue 8
  • DOI: 10.1128/JVI.02660-07

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
journal, July 2004

  • Traggiai, Elisabetta; Becker, Stephan; Subbarao, Kanta
  • Nature Medicine, Vol. 10, Issue 8
  • DOI: 10.1038/nm1080

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
journal, June 1998

  • Kwong, Peter D.; Wyatt, Richard; Robinson, James
  • Nature, Vol. 393, Issue 6686
  • DOI: 10.1038/31405

Role of V1V2 and Other Human Immunodeficiency Virus Type 1 Envelope Domains in Resistance to Autologous Neutralization during Clade C Infection
journal, November 2007

  • Rong, Rong; Bibollet-Ruche, Frederic; Mulenga, Joseph
  • Journal of Virology, Vol. 81, Issue 22
  • DOI: 10.1128/jvi.01904-07

Development of the antibody response in acute HIV-1 infection
journal, January 2004


Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India
journal, March 2009


Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates
journal, February 2001


Understanding and making use of human memory B cells
journal, June 2006


Envelope-Constrained Neutralization-Sensitive HIV-1 After Heterosexual Transmission
journal, March 2004


Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
journal, January 2006


Rapid evolution of the neutralizing antibody response to HIV type 1 infection
journal, March 2003

  • Richman, D. D.; Wrin, T.; Little, S. J.
  • Proceedings of the National Academy of Sciences, Vol. 100, Issue 7
  • DOI: 10.1073/pnas.0630530100

Molecular architecture of native HIV-1 gp120 trimers
journal, July 2008

  • Liu, Jun; Bartesaghi, Alberto; Borgnia, Mario J.
  • Nature, Vol. 455, Issue 7209
  • DOI: 10.1038/nature07159

Subtype-Specific Conformational Differences within the V3 Region of Subtype B and Subtype C Human Immunodeficiency Virus Type 1 Env Proteins
journal, November 2007

  • Patel, Milloni B.; Hoffman, Noah G.; Swanstrom, Ronald
  • Journal of Virology, Vol. 82, Issue 2
  • DOI: 10.1128/JVI.01444-07

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III
journal, May 1985


Clade-Specific Differences between Human Immunodeficiency Virus Type 1 Clades B and C: Diversity and Correlations in C3-V4 Regions of gp120
journal, May 2007

  • Gnanakaran, S.; Lang, Dorothy; Daniels, Marcus
  • Journal of Virology, Vol. 81, Issue 9
  • DOI: 10.1128/JVI.01954-06

Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients
journal, May 1985


Antibody neutralization and escape by HIV-1
journal, March 2003

  • Wei, Xiping; Decker, Julie M.; Wang, Shuyi
  • Nature, Vol. 422, Issue 6929
  • DOI: 10.1038/nature01470

Appreciating HIV Type 1 Diversity: Subtype Differences in Env
journal, March 2009

  • Lynch, Rebecca M.; Shen, Tongye; Gnanakaran, S.
  • AIDS Research and Human Retroviruses, Vol. 25, Issue 3
  • DOI: 10.1089/aid.2008.0219

Antigenic conservation and immunogenicity of the HIV coreceptor binding site
journal, May 2005

  • Decker, Julie M.; Bibollet-Ruche, Frederic; Wei, Xiping
  • The Journal of Experimental Medicine, Vol. 201, Issue 9
  • DOI: 10.1084/jem.20042510

Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing
text, January 2008

  • B., Guffey, M.; A., Anderson, J.; M., Korber, B. T.
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/hzzw-gs19

Determinants of Neutralization Resistance in the Envelope Glycoproteins of a Simian-Human Immunodeficiency Virus Passaged In Vivo
journal, October 1999


Structures of HIV-1 gp120 Envelope Glycoproteins from Laboratory-Adapted and Primary Isolates
journal, December 2000


Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza
journal, May 2007


HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites
journal, December 2002

  • Kwong, Peter D.; Doyle, Michael L.; Casper, David J.
  • Nature, Vol. 420, Issue 6916
  • DOI: 10.1038/nature01188

Structure of an unliganded simian immunodeficiency virus gp120 core
journal, February 2005

  • Chen, Bing; Vogan, Erik M.; Gong, Haiyun
  • Nature, Vol. 433, Issue 7028
  • DOI: 10.1038/nature03327

High frequencies of antibody responses to CD4 induced epitopes in HIV infected patients started on HAART during acute infection
journal, May 2006

  • Robinson, James E.; Elliott, Debra Holton; Martin, Effie A.
  • Human Antibodies, Vol. 14, Issue 3-4
  • DOI: 10.3233/HAB-2005-143-408

Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1
journal, January 2009


Characterization of CD4-Induced Epitopes on the HIV Type 1 gp120 Envelope Glycoprotein Recognized by Neutralizing Human Monoclonal Antibodies
journal, November 2002

  • Xiang, Shi-Hua; Doka, Najah; Choudhary, Rabeéa K.
  • AIDS Research and Human Retroviruses, Vol. 18, Issue 16
  • DOI: 10.1089/08892220260387959

Identification of Conserved and Variant Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 by Human Monoclonal Antibodies Produced by EBV-Transformed Cell Lines
journal, May 1990

  • Robinson, James E.; Holton, Debra; Pacheco-Morell, Susan
  • AIDS Research and Human Retroviruses, Vol. 6, Issue 5
  • DOI: 10.1089/aid.1990.6.567

A role for carbohydrates in immune evasion in AIDS
journal, June 1998

  • Reitter, Julie N.; Means, Robert E.; Desrosiers, Ronald C.
  • Nature Medicine, Vol. 4, Issue 6
  • DOI: 10.1038/nm0698-679

Subtype-Specific Conformational Differences within the V3 Region of Subtype B and Subtype C Human Immunodeficiency Virus Type 1 Env Proteins
text, January 2008

  • G., Hoffman, N.; B., Patel, M.; R., Swanstrom,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/7a71-wv26

The Challenge of HIV-1 Subtype Diversity
journal, October 2008

  • Taylor, Barbara S.; Hammer, Scott M.
  • New England Journal of Medicine, Vol. 359, Issue 18
  • DOI: 10.1056/nejmc086373

Neutralizing Antibody Responses in Acute Human Immunodeficiency Virus Type 1 Subtype C Infection
journal, April 2007

  • Gray, E. S.; Moore, P. L.; Choge, I. A.
  • Journal of Virology, Vol. 81, Issue 12
  • DOI: 10.1128/JVI.00239-07

The Challenge of HIV-1 Subtype Diversity
journal, April 2008

  • Taylor, Barbara S.; Sobieszczyk, Magdalena E.; McCutchan, Francine E.
  • New England Journal of Medicine, Vol. 358, Issue 15
  • DOI: 10.1056/NEJMra0706737

Characterization of Immune Escape Viruses from a Macaque Immunized with Live-Virus Vaccine and Challenged with Pathogenic SHIV KU-1
journal, October 2000

  • Stipp, Heather L.; Kumar, Anil; Narayan, Opendra
  • AIDS Research and Human Retroviruses, Vol. 16, Issue 15
  • DOI: 10.1089/088922200750006092

Antigenic Variation of SIV: Mutations in V4 Alter the Neutralization Profile
journal, July 1996

  • Kinsey, Nicole E.; Anderson, Mark G.; Unangst, Tami J.
  • Virology, Vol. 221, Issue 1
  • DOI: 10.1006/viro.1996.0348

Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection
journal, December 2005

  • Frost, S. D. W.; Wrin, T.; Smith, D. M.
  • Proceedings of the National Academy of Sciences, Vol. 102, Issue 51
  • DOI: 10.1073/pnas.0504658102

The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Human Immunodeficiency Virus Type 1 Subtype C Infection
journal, December 2007

  • Moore, Penny L.; Gray, Elin S.; Choge, Isaac A.
  • Journal of Virology, Vol. 82, Issue 4
  • DOI: 10.1128/JVI.02187-07

Structural definition of a conserved neutralization epitope on HIV-1 gp120
journal, February 2007


Evidence for Potent Autologous Neutralizing Antibody Titers and Compact Envelopes in Early Infection with Subtype C Human Immunodeficiency Virus Type 1
journal, November 2007

  • Li, Bing; Decker, Julie M.; Johnson, Roy W.
  • Journal of Virology, Vol. 81, Issue 22
  • DOI: 10.1128/jvi.01905-07

Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma
journal, November 2008

  • Davis, Katie L.; Bibollet-Ruche, Frederic; Li, Hui
  • Journal of Virology, Vol. 83, Issue 3
  • DOI: 10.1128/JVI.01743-08

Role of V1V2 and Other Human Immunodeficiency Virus Type 1 Envelope Domains in Resistance to Autologous Neutralization during Clade C Infection
journal, November 2006

  • Rong, Rong; Bibollet-Ruche, Frederic; Mulenga, Joseph
  • Journal of Virology, Vol. 81, Issue 3
  • DOI: 10.1128/JVI.01839-06

Works referencing / citing this record:

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
text, January 2013

  • Lacerda, Miguel; Moore, Penny; Ngandu, Nobubelo
  • Columbia University
  • DOI: 10.7916/d8n29vf6

Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies
journal, August 2018


Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity
journal, October 2016

  • VanBlargan, Laura A.; Goo, Leslie; Pierson, Theodore C.
  • Microbiology and Molecular Biology Reviews, Vol. 80, Issue 4
  • DOI: 10.1128/mmbr.00024-15

Antibody Selection and Amino acid Reversions: Antibody Selection
journal, May 2012


Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
journal, July 2010

  • Zolla-Pazner, Susan; Cardozo, Timothy
  • Nature Reviews Immunology, Vol. 10, Issue 7
  • DOI: 10.1038/nri2801

A Novel CCR5 Mutation Common in Sooty Mangabeys Reveals SIVsmm Infection of CCR5-Null Natural Hosts and Efficient Alternative Coreceptor Use In Vivo
journal, August 2010


Sequences in Glycoprotein gp41, the CD4 Binding Site, and the V2 Domain Regulate Sensitivity and Resistance of HIV-1 to Broadly Neutralizing Antibodies
journal, August 2012

  • O'Rourke, S. M.; Schweighardt, B.; Phung, P.
  • Journal of Virology, Vol. 86, Issue 22
  • DOI: 10.1128/jvi.01352-12

Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens
journal, March 2016

  • Hessell, Ann J.; Malherbe, Delphine C.; Pissani, Franco
  • The Journal of Immunology, Vol. 196, Issue 7
  • DOI: 10.4049/jimmunol.1500527

Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies
journal, December 2018

  • Mabvakure, Batsirai M.; Scheepers, Cathrine; Garrett, Nigel
  • Journal of Virology, Vol. 93, Issue 6
  • DOI: 10.1128/jvi.01685-18

Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses
journal, February 2018

  • Ashokkumar, Manickam; Aralaguppe, Shambhu G.; Tripathy, Srikanth P.
  • Journal of Virology, Vol. 92, Issue 9
  • DOI: 10.1128/jvi.00063-18

Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus Escape
journal, May 2012


Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections
journal, September 2011


Characterization of Acute HIV-1 Infection in High-Risk Nigerian Populations
journal, February 2012

  • Charurat, Man; Nasidi, Abdulsalami; Delaney, Kevin
  • The Journal of Infectious Diseases, Vol. 205, Issue 8
  • DOI: 10.1093/infdis/jis103

Previously Transmitted HIV-1 Strains Are Preferentially Selected During Subsequent Sexual Transmissions
journal, November 2012

  • Redd, Andrew D.; Collinson-Streng, Aleisha N.; Chatziandreou, Nikolaos
  • The Journal of Infectious Diseases, Vol. 206, Issue 9
  • DOI: 10.1093/infdis/jis503

R5 Clade C SHIV Strains with Tier 1 or 2 Neutralization Sensitivity: Tools to Dissect Env Evolution and to Develop AIDS Vaccines in Primate Models
journal, July 2010


HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
journal, July 2016

  • van den Kerkhof, Tom L. G. M.; de Taeye, Steven W.; Boeser-Nunnink, Brigitte D.
  • Retrovirology, Vol. 13, Issue 1
  • DOI: 10.1186/s12977-016-0279-4

HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
journal, November 2018


Impact of HIV-1 Diversity on Its Sensitivity to Neutralization
journal, July 2019


Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients
journal, January 2015


HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV
journal, January 2011

  • Cicala, Claudia; Arthos, James; Fauci, Anthony S.
  • Journal of Translational Medicine, Vol. 9, Issue S1
  • DOI: 10.1186/1479-5876-9-s1-s2

Antibody responses to envelope glycoproteins in HIV-1 infection
journal, May 2015

  • Burton, Dennis R.; Mascola, John R.
  • Nature Immunology, Vol. 16, Issue 6
  • DOI: 10.1038/ni.3158

Prime-Boost Immunization of Rabbits with HIV-1 gp120 Elicits Potent Neutralization Activity against a Primary Viral Isolate
journal, January 2013


Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
journal, January 2013

  • Lacerda, Miguel; Moore, Penny L.; Ngandu, Nobubelo K.
  • Virology Journal, Vol. 10, Issue 1
  • DOI: 10.1186/1743-422x-10-347

Gp120 V5 Is Targeted by the First Wave of Sequential Neutralizing Antibodies in SHIVSF162P3N-Infected Rhesus Macaques
journal, May 2018

  • Jia, Manxue; Lu, Hong; Kong, Xiang-Peng
  • Viruses, Vol. 10, Issue 5
  • DOI: 10.3390/v10050262

HIV-1 transmission and viral adaptation to the host
journal, January 2012

  • Gijsbers, Esther F.; Schuitemaker, Hanneke; Kootstra, Neeltje A.
  • Future Virology, Vol. 7, Issue 1
  • DOI: 10.2217/fvl.11.134

Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies
journal, December 2018

  • Mabvakure, Batsirai M.; Scheepers, Cathrine; Garrett, Nigel
  • Journal of Virology, Vol. 93, Issue 6
  • DOI: 10.1128/jvi.01685-18

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
journal, April 2020


HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV
journal, January 2011

  • Cicala, Claudia; Arthos, James; Fauci, Anthony S.
  • Journal of Translational Medicine, Vol. 9, Issue S1
  • DOI: 10.1186/1479-5876-9-s1-s2

HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection
journal, September 2012


HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
journal, July 2016

  • van den Kerkhof, Tom L. G. M.; de Taeye, Steven W.; Boeser-Nunnink, Brigitte D.
  • Retrovirology, Vol. 13, Issue 1
  • DOI: 10.1186/s12977-016-0279-4

HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
journal, November 2018


Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein
journal, October 2016


Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies
journal, August 2018


VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120
journal, January 2019

  • Smith, S. Abigail; Burton, Samantha L.; Kilembe, William
  • Frontiers in Immunology, Vol. 9
  • DOI: 10.3389/fimmu.2018.03163

Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies
journal, May 2019

  • Hutchinson, Jennie M.; Mesa, Kathryn A.; Alexander, David L.
  • Frontiers in Immunology, Vol. 10
  • DOI: 10.3389/fimmu.2019.01021

The Janus Face of Follicular T Helper Cells in Chronic Viral Infections
text, January 2018


Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
text, January 2013

  • Lacerda, Miguel; Moore, Penny; Ngandu, Nobubelo
  • Columbia University
  • DOI: 10.7916/d8n29vf6